InsidersTradesSigma
Atrys Health, S.A. Stock: price and directors' dealings · Spain · CNMV
Track the Atrys Health, S.A. share price and the full directors' dealings record of the company, a listed issuer based in Spain. Shares trade on ES ES, under the oversight of CNMV. Operating in the Healthcare & Pharma sector, Atrys Health, S.A. has recorded 54 public disclosures. Market capitalisation: €194.7m. The latest transaction was disclosed on 9 July 2026 (Purchase). Among the most active insiders: Santiago de Torres Sanahuja. The full history is openly available.
54
Insider Decl.
0
Thresholds
€6m
43 ops.
Buy Volume
€26m
11 ops.
Sell Volume
34Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,100 of 25,927 companies
18.5
score / 100
Value12
Quality25
FCF yld-7.4%
Earn yld-53%
EV/EBITDA·
ROE-27%
Gross mgn44%
Net mgn-71%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 9 July 2026
Declarations54 total
20,000 shares@ €2.580.026% mcap39.1% of flowShareXMADCNMV:2026095230
Ideal exit: 26 Mar 2027 (T+270)
5,000 shares@ €2.990.0073% mcap50.0% of flowShareXMADCNMV:2026056017
5,000 shares@ €2.990.0073% mcap50.0% of flowShareXMADCNMV:2026051348
Ideal exit: 10 Jan 2027 (T+270)
4,000 shares@ €2.750.0054% mcap100.0% of flowShareXMADCNMV:2026048808
11,000 shares@ €2.700.015% mcap36.9% of flowShareXMADCNMV:2026048065
Ideal exit: 26 Dec 2026 (T+270)
18,000 shares@ €2.820.025% mcap63.1% of flowShareXMADCNMV:2025141315
Ideal exit: 14 Aug 2026 (T+270)
1,000 shares@ €3.860.0019% mcap100.0% of flowShareXMADCNMV:2024075458
5,000 shares@ €2.900.0071% mcap10.1% of flowShareBMEXCNMV:2024065780
Ideal exit: 4 Feb 2025 (T+270)
399 shares@ €3.620.0007% mcap1.0% of flowShareBMEXCNMV:2024065794
Ideal exit: 8 Feb 2025 (T+270)
5,000 shares@ €2.900.0071% mcap10.1% of flowShareBMEXCNMV:2024065281
Ideal exit: 4 Feb 2025 (T+270)
33,730 shares@ €3.300.054% mcap77.7% of flowShareBMEXCNMV:2024065287
Ideal exit: 7 Feb 2025 (T+270)
399 shares@ €3.620.0007% mcap1.0% of flowShareBMEXCNMV:2024065295
Ideal exit: 8 Feb 2025 (T+270)
1,000 shares@ €3.920.0019% mcap17.0% of flowShareXMADCNMV:2023136120
Ideal exit: 16 Aug 2024 (T+270)
62 shares@ €4.000.0001% mcap11.7% of flowShareXMADCNMV:2023124870
Ideal exit: 13 Jul 2024 (T+270)
26 shares@ €4.000.0001% mcap4.9% of flowShareXMADCNMV:2023124883
Ideal exit: 1 Jul 2024 (T+270)
1,000 shares@ €3.890.0019% mcap16.8% of flowShareXMADCNMV:2023117179
Ideal exit: 25 Jun 2024 (T+270)
5,000 shares@ €4.940.012% mcap100.0% of flowShareXMADCNMV:2023105251
Ideal exit: 22 Apr 2024 (T+270)
43 shares@ €4.980.0001% mcap10.1% of flowShareXMADCNMV:2023060092
Ideal exit: 15 Jan 2024 (T+270)
23 shares@ €5.020.0001% mcap5.5% of flowShareXMADCNMV:2023060093
Ideal exit: 14 Jan 2024 (T+270)
30 shares@ €5.080.0001% mcap7.2% of flowShareXMADCNMV:2023060094
Ideal exit: 13 Jan 2024 (T+270)
150 shares@ €5.080.0004% mcap36.1% of flowShareXMADCNMV:2023060095
Ideal exit: 12 Jan 2024 (T+270)
32 shares@ €5.150.0001% mcap7.8% of flowShareXMADCNMV:2023060098
Ideal exit: 9 Jan 2024 (T+270)
14 shares@ €5.360.0000% mcap3.6% of flowShareXMADCNMV:2023060099
Ideal exit: 7 Jan 2024 (T+270)
52 shares@ €5.330.0001% mcap13.1% of flowShareXMADCNMV:2023060100
Ideal exit: 30 Jan 2024 (T+270)
1,506 shares@ €5.140.0038% mcap6.0% of flowShareXMADCNMV:2023059129
Ideal exit: 30 Jan 2024 (T+270)
25 of 54 declarations
About Atrys Health, S.A.
ATRYS HEALTH, S.A. is a company focused on the healthcare and pharmaceutical sector, providing innovative solutions for the diagnosis and treatment of diseases. It is listed on the XMAD market.
